These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease. Furukawa F; Ishikawa K; Yokota T; Sanjo N Eur Neurol; 2019; 81(1-2):13-18. PubMed ID: 31013498 [TBL] [Abstract][Full Text] [Related]
27. Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl I-123 p-iodoamphetamine: concise communication. Hill TC; Holman BL; Lovett R; O'Leary DH; Front D; Magistretti P; Zimmerman RE; Moore S; Clouse ME; Wu JL; Lin TH; Baldwin RM J Nucl Med; 1982 Mar; 23(3):191-5. PubMed ID: 6977624 [TBL] [Abstract][Full Text] [Related]
28. I-123 Iofetamine SPECT scan in children with neurological disorders. Flamini JR; Konkol RJ; Wells RG; Sty JR Wis Med J; 1990 Oct; 89(10):584-7. PubMed ID: 2238681 [TBL] [Abstract][Full Text] [Related]
29. Critical cerebral blood flow thresholds studied by SPECT using xenon-133 and iodine-123 iodoamphetamine. Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K J Nucl Med; 1989 Mar; 30(3):337-42. PubMed ID: 2786938 [TBL] [Abstract][Full Text] [Related]
30. Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease. Kuwert T; Lange HW; Langen KJ; Herzog H; Aulich A; Feinendegen LE Psychiatry Res; 1989 Sep; 29(3):361-2. PubMed ID: 2532753 [No Abstract] [Full Text] [Related]
33. Single photon emission computed tomography (SPECT) with [123I]IMP in the differential diagnosis of psychiatric disorders. O'Connell RA; Van Heertum RL; Billick SB; Holt AR; Gonzalez A; Notardonato H; Luck D; King LN J Neuropsychiatry Clin Neurosci; 1989; 1(2):145-53. PubMed ID: 2521055 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of regional cerebral blood flow in hippocampus by 99mTc-ECD SPECT: comparison with 123I-IMP SPECT]. Matsumura K; Watanabe Y; Aoki S; Nakashima H; Maeda H; Hirano T; Takeda K; Nakagawa T Kaku Igaku; 1996 Sep; 33(9):1021-6. PubMed ID: 8921672 [TBL] [Abstract][Full Text] [Related]
35. Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease? Lang C Neuroradiology; 1985; 27(2):161-3. PubMed ID: 3157882 [TBL] [Abstract][Full Text] [Related]
36. Temporal evolution of brain distribution of IMP and HIPDM. Concise communication. Moretti JL; Kung HF; Cesaro P; Blau M; Defer G; Holman L; Vigneron N; Rapin JR Nucl Med Commun; 1987 Jul; 8(7):597-602. PubMed ID: 3500438 [TBL] [Abstract][Full Text] [Related]
37. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates. Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772 [TBL] [Abstract][Full Text] [Related]
38. Single photon emission computed tomography in subjects at risk for Huntington's chorea. Leblhuber F; Brucker B; Reisecker F; Steinparz F; Windhager E; Trenkler J; Deisenhammer E J Neurol; 1990 Dec; 237(8):496-8. PubMed ID: 2150077 [No Abstract] [Full Text] [Related]
39. Neuropathologic correlation of computerized tomography in Huntington's disease. Terrence CF; Rao G South Med J; 1980 Jun; 73(6):817-8. PubMed ID: 6446759 [TBL] [Abstract][Full Text] [Related]
40. Regional quantitative noninvasive assessment of cerebral perfusion and function with N-isopropyl-[123I]p-iodoamphetamine. von Schulthess GK; Ketz E; Schubiger PA; Bekier A J Nucl Med; 1985 Jan; 26(1):9-16. PubMed ID: 3965658 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]